CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-1 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 885,417 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 48 of 50 · 1,000 filings